Atherosclerotic Vascular Disease Conference

Richard C. Pasternak; Michael H. Criqui; Emelia Benjamin; F.G.R. Fowkes; Eric M. Isselbacher; Peter A. McCullough; Philip A. Wolf; Zhijie Zheng

doi:10.1161/01.cir.0000128518.26834.93

Article1994

Atherosclerotic risk factors in abdominal aortic aneurysm and peripheral vascular occlusive disease

Colleen Cole, Gerry Hill, Alain Bouchard, David Moher, Emami Farzad, Kelly Rody, Beverley Shea

Article2021

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease

Emily Sammons, Jemma C. Hopewell, Fang Chen, William Stevens, Karl Wallendszus, Elsa Valdés‐Márquez, R. Dayanandan, Carol Knott, Keefe Murphy, E. Wincott, Alex Baxter, Richard D. Goodenough, M Lay, Michael Hill, Scott M. MacDonnell, Gianna Fabbri, Donata Lucci, M Fajardo-Moser, Susanne Brenner, D Hao, H Zhang, Jiamin Liu, Bi-li-ge Wuhan, Sebastian Breddam Mosegaard, William G. Herrington, Christoph Wanner, C Angermann, Georg Ertl, Aldo Maggioni, Philip J. Barter, Borislava Mihaylova, Yale Mitchel, Robert O. Blaustein, Seiichi Goto, Jonathan A. Tobert, Paul DeLucca, Y Chen, Z Chen, Alastair Gray, Richard Haynes, Jane Armitage, Colin Baigent, Stephen D. Wiviott, Christopher P. Cannon, Eugene Braunwald, Rory Collins, Louise Bowman, Martin Landray

Article2022

Circadian rhythms of risk factors and management in atherosclerotic and hypertensive vascular disease: Modern chronobiological perspectives of an ancient disease

Yong‐Jian Geng, Michael H. Smolensky, Oliver Sum‐Ping, Ramon C Hermida, Richard J. Castriotta

Article2011

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update

Sidney C. Smith, Emelia Benjamin, Robert O. Bonow, Lynne T. Braun, Mark A. Creager, Barry A. Franklin, Raymond J. Gibbons, Scott M. Grundy, Loren F. Hiratzka, Daniel W. Jones, Donald M. Lloyd‐Jones, Margo Minissian, Lori Mosca, Eric D. Peterson, Ralph L. Sacco, John A. Spertus, James H. Stein, Kathryn A. Taubert

Article2011

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update

Sidney C. Smith, Emelia Benjamin, Robert O. Bonow, Lynne T. Braun, Mark A. Creager, Barry A. Franklin, Raymond J. Gibbons, Scott M. Grundy, Loren F. Hiratzka, Daniel W. Jones, Donald M. Lloyd‐Jones, Margo Minissian, Lori Mosca, Eric D. Peterson, Ralph L. Sacco, John A. Spertus, James H. Stein, Kathryn A. Taubert

Atherosclerotic Vascular Disease Conference

Discussion(0)

Related publications

Atherosclerotic risk factors in abdominal aortic aneurysm and peripheral vascular occlusive disease

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease

Circadian rhythms of risk factors and management in atherosclerotic and hypertensive vascular disease: Modern chronobiological perspectives of an ancient disease

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update